The histamine-2 receptor antagonists revolutionized the treatment of acid peptic disorders owing to their safety and efficacy profile. The proton-pump inhibitors (PPIs) represent a further ...

Tel Aviv University-led research has found that infants prescribed acid-suppressive medications during their first six months of life had an increased risk of developing celiac disease autoimmunity ...

Many people in the United States take medications called proton pump inhibitors, or PPIs, to help with heartburn, acid reflux ...

Vogt produce histamine synthetically by removing ... 1972—James Black discovers the H2 receptor and characterizes its antagonist, burimamide. 1999—Researchers at a subsidiary of Johnson ...

Famotidine is a competitive inhibitor of histamine-2 (H2) receptors. The primary clinically important pharmacologic activity of famotidine is inhibition of gastric secretion. Both the acid ...

Abstract and Introduction Predicting and Establishing the Clinical Efficacy of a Histamine H Application ... evaluating the efficacy of the H 1-receptor antagonist desloratadine.

Yet, many people with PMDD are turning to antihistamines, as well as famotidine—a histamine receptor antagonist which blocks histamine production in the stomach—to reduce PMDD symptoms.